Medtronic has obtained a pair of major green lights from the FDA for its flagship insulin pump—opening up the MiniMed 780G to adults with type 2 diabetes in the U.S., and allowing it to c | ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The Abbott Libre Rio was cleared for adults with type 2 ...

MOBILE, Ala. (WALA) - The stakes are extremely high for the nearly 40 million Americans living with diabetes. This condition happens when the body doesn’t produce enough insulin or is unable to use ...

A revolution in how Americans fight obesity and burgeoning cases of Type 2 diabetes could be brewing as Abbott Laboratories and its close competitor Dexcom start putting a variety of continuous ...

BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing technology, is proud to announce that the Dexcom G7 Continuous Glucose Monitoring (CGM) ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Carol H. Wysham, ...

Diabetes has long been lumped into two categories - Type 1, which often appears in childhood, or Type 2, which is associated with obesity and typically develops later in life. But scientists have ...

I saw a patient a few years ago who had come to me because he had been using a continuous glucose monitor (CGM), despite not having diabetes, and was worried about what he called "glucose spikes" ...

A new narrative review 1 led by researchers at UCL and Birmingham Children’s Hospital has found there is a lack of evidence to demonstrate the effective use of continuous glucose monitors (CGMs) in ...

Alberta Government is now covering Dexcom G7, providing eligible residents living with either type 1 or type 2 diabetes with increased access to the life-changing technology Alberta residents living ...